Chun-Che Liao

发表

The Effectiveness of Far-Ultraviolet (UVC) Light Prototype Devices with Different Wavelengths on Disinfecting SARS-CoV-2

H. Kuo, Yi-Ling Lin, Kuang-Mao Lu, 2021, Applied Sciences.

Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants

M. Lai, Yi-Ling Lin, Y. Kao, 2021, International journal of molecular sciences.

Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model

Chun-Che Liao, Chih-Shin Chang, C. Shih, 2019, Journal of Biomedical Science.

A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants

F. Guirakhoo, T. Monath, Hope Liu, 2022, The Journal of clinical investigation.

Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2

C. Chen, Szu-Huei Wu, Shiow-Ju Lee, 2021, Frontiers in Pharmacology.

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study

J. Jan, K. Tsai, Yi-Ling Lin, 2020, Biomedicine & Pharmacotherapy.

Enterovirus 71 targets the cardiopulmonary system in a robust oral infection mouse model

Ya-Ting Chang, Chien-Chang Chen, Chun-Che Liao, 2019, Scientific Reports.

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants

S. Hsu, Po-Cheng Chiang, Y. Chou, 2022, Journal of biomedical science.

Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy

Chun-Che Liao, Chih-Shin Chang, C. Shih, 2018, Viruses.

A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71

Chun-Che Liao, Chih-Shin Chang, C. Shih, 2016, Scientific Reports.

The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b

C. Chen, R. Yang, Shiow-Ju Lee, 2022, Pharmaceutics.

A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern

J. Jan, I-Hsuan Wang, Yi-Ling Lin, 2022, Emerging microbes & infections.

Novel Naturally Occurring Mutations of Enterovirus 71 Associated With Disease Severity

M. Hwang, Chun-Che Liao, Chih-Shin Chang, 2021, Frontiers in Microbiology.

Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives

C. Chen, Szu-Huei Wu, J. Jan, 2020, Frontiers in Pharmacology.

Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19

Yun-Ju Lai, J. Jan, Y. Ko, 2021, PLoS Pathogens.

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters

Che Ma, J. Jan, C-F Kao, 2021, bioRxiv.

Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis.

Shing-Jyh Chang, Yun-Ju Lai, J. Hsu, 2021, American journal of cancer research.

Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.

Shing-Jyh Chang, Yun-Ju Lai, J. Hsu, 2021, American journal of cancer research.

NK cell receptor and ligand composition influences the clearance of SARS-CoV-2.

Yun-Ju Lai, Hsiang-Chi Huang, Huai-Kuang Tsai, 2021, The Journal of clinical investigation.

Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion

L. McCullough, Yun-Ju Lai, J. Jan, 2023, Journal of medical virology.

Immunodeficient Mouse Models with Different Disease Profiles by In Vivo Infection with the Same Clinical Isolate of Enterovirus 71

P. Tu, Chun-Che Liao, Chih-Shin Chang, 2014, Journal of Virology.

A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants

S. Hsu, Po-Cheng Chiang, Y. Chou, 2022, Journal of biomedical science.

Structure-guided antibody cocktail for prevention and treatment of COVID-19

J. Jan, S. Hsu, Yi-Ling Lin, 2021, PLoS pathogens.

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge

J. Jan, M. Tao, Ping-Yi Wu, 2021, Scientific Reports.

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan

Shinn-Jang Hwang, Wen-Sen Lee, M. Liu, 2021, The Lancet Respiratory Medicine.

Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan

J. Wu, Shung-Haur Yang, Yi-Ling Lin, 2023, Journal of Microbiology, Immunology and Infection.

Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro

Yun-Ju Lai, J. Hsu, Hsiang-Chi Huang, 2021, EBioMedicine.

Optimization and Improvement of qPCR Detection Sensitivity of SARS-CoV-2 in Saliva

Wen-Chun Liu, Chun-Che Liao, Chih-Shin Chang, 2023, Microbiology spectrum.

Hypoxia and therapeutic treatment of EV-A71 with an immune modulator TLR7 agonist in a new immunocompetent mouse model

Chun-Che Liao, Chih-Shin Chang, C. Shih, 2019, Journal of Biomedical Science.

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan

M. Liu, J. Chiou, Yi-Ling Lin, 2022, Vaccines.

Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin.

J. Jan, Shiow-Ju Lee, Sui‐Yuan Chang, 2023, Biochemical pharmacology.

Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission

Jian-Jong Liang, Chun-Che Liao, Chih-Shin Chang, 2023, Journal of Biomedical Science.

Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody

Jian-Jong Liang, Chao-Ping Tung, Yi-Hua Chen, 2024, JCI insight.